Supercritical CO2 Extraction in Pharmaceuticals: Driving Innovation and Purity Standards
Supercritical CO2 pharmaceutical extraction is becoming the preferred method for producing botanical active pharmaceutical ingredients (APIs) at clinical and commercial scale. The reason is straightforward: it produces zero residual solvent – meaning no ICH Q3C limits apply – while operating at low temperatures (35–80°C) that preserve heat-sensitive compounds. Understanding the supercritical fluid extraction advantages and …
Supercritical CO2 Extraction in Pharmaceuticals: Driving Innovation and Purity Standards Read More »







